Inactive Instrument

News Qlife Holding AB (publ) Nasdaq Stockholm

Equities

SE0013486552

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Qlife Places Danish Operational Company in Reconstruction Mode	Apr. 05	MT
Qlife informs that it has put its Danish operational company into reconstruction mode as a temporary measure	Apr. 04	AQ
Sweden's Qlife to Launch Biomarker Testing Platform in South Korea Via Potential Partnership	Mar. 25	MT
Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships	Mar. 25	AQ
Qlife Signs Letter of Intent with Precision Biosensor	Mar. 25	CI
Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.	Mar. 21	AQ
Qlife Secures Core Patent for Egoo System in EU, UK Markets	Feb. 23	MT
Qlife Announces its Core Patent for Egoo System Grants in EU and Other Countries in European Market, as Well as in United Kingdom	Feb. 23	CI
Qlife Holding AB Announces Update on Collaboration with Hipro Biotechnology	Feb. 16	CI
Qlife publishes prospectus due to upcoming rights issue of units	Feb. 09	AQ
Qlife Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 09	CI
Qlife Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 09	CI
Qlife Holding AB Postpones the Publication of the Year-End Report for the Financial Year 2023 Until 8 February 2024	Feb. 04	CI
Bulletin from the extraordinary general meeting in Qlife Holding AB on 16 January 2024	Jan. 16	AQ
Notice of extraordinary general meeting in Qlife Holding AB	Dec. 12	AQ
Qlife carries out a rights issue of units of approximately SEK 49.5 million	Dec. 12	AQ
Qlife collaboration agreement with Hipro biotechnology - potential value of 500 MSEK	Dec. 07	AQ
Qlife Enters Collaboration Agreement with Hipro Biotechnology	Dec. 07	CI
Qlife, Hipro Biotechnology Ink Collaboration Deal for Egoo Health; Shares Soar	Dec. 04	MT
Qlife Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Qlife Holding AB (publ) Nasdaq Stockholm

Equities

SE0013486552

Summary

Filters